Tchaikovski S N, VAN Vlijmen B J M, Rosing J, Tans G
Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherland.
J Thromb Haemost. 2007 Oct;5(10):2079-86. doi: 10.1111/j.1538-7836.2007.02719.x. Epub 2007 Jul 31.
Mouse models have become increasingly important in thrombosis research. However, only a limited number of assays are available for assessment of the coagulation system in mouse plasma.
To quantify tissue factor-initiated thrombin generation in murine platelet-rich and platelet-free plasma and to develop a test for measurement of resistance to activated protein C (APC) in mouse plasma.
Thrombin generation was monitored with calibrated automated thrombography (CAT) using a low-affinity fluorogenic substrate for thrombin.
To overcome the higher activity of coagulation inhibitors in mouse plasma as compared with human plasma, the reaction temperature was lowered to 33 degrees C and the assay was carried out at a 2-fold higher final plasma dilution (1:3) than commonly used for CAT in human plasma. This increased the endogenous thrombin potential (ETP) 4- to 5-fold and enabled reliable measurement of thrombin generation in both platelet-free and platelet-rich mouse plasma. For the APC resistance measurement, the reaction conditions were further optimized with respect to tissue factor, phospholipid, APC and CaCl(2) concentrations. The test was validated using plasma of mice with different genetic background with respect to the factor V Leiden mutation (FV Leiden). Mice homozygous for FV Leiden had higher APC sensitivity ratios (mean 5.46; 95% CI 4.88-6.03) than heterozygous FV Leiden mice (mean 4.21; 95% CI 3.53-4.89) and than wild-type mice (mean 2.71; 95%CI 2.15-3.27).
We have established reaction conditions for measurement of thrombin generation and APC resistance in mouse plasma. This assay enables evaluation of the coagulation system and the function of the protein C system in mouse models.
小鼠模型在血栓形成研究中变得越来越重要。然而,用于评估小鼠血浆中凝血系统的检测方法数量有限。
量化组织因子启动的富含血小板和无血小板小鼠血浆中的凝血酶生成,并开发一种检测小鼠血浆中活化蛋白C(APC)抵抗性的方法。
使用校准自动血栓形成仪(CAT),通过一种对凝血酶亲和力低的荧光底物监测凝血酶生成。
为克服小鼠血浆中凝血抑制剂活性高于人血浆的问题,将反应温度降至33℃,且检测时血浆最终稀释倍数比人血浆中CAT常用的高2倍(1:3)。这使内源性凝血酶潜力(ETP)增加了4至5倍,并能够可靠地测量无血小板和富含血小板小鼠血浆中的凝血酶生成。对于APC抵抗性检测,在组织因子、磷脂、APC和氯化钙浓度方面进一步优化了反应条件。使用具有不同遗传背景的小鼠血浆,针对因子V莱顿突变(FV莱顿)对该检测进行了验证。FV莱顿纯合子小鼠的APC敏感性比值(平均5.46;95%可信区间4.88 - 6.03)高于FV莱顿杂合子小鼠(平均4.21;95%可信区间3.53 - 4.89)和野生型小鼠(平均2.71;95%可信区间2.15 - 3.27)。
我们已经建立了用于测量小鼠血浆中凝血酶生成和APC抵抗性的反应条件。该检测能够评估小鼠模型中的凝血系统和蛋白C系统功能。